AI-powered, patient-matched solution aims to simplify Lapidus procedures and enhance surgical outcomes...
Partnership aims for CAP/CLIA certification of organoid-based assay to guide patient-specific treatment decisions; $10 million investment to fuel clinical validation across multiple cancer types ...
By aligning regulatory rigour with technological complexity, the FDA safeguards public health while accelerating access to life-changing medical innovations through adaptive pathways and total lifecycle vigilance...
First and only purpose-built solution delivering rapid and complete luminal clot removal in small vessel and arteriovenous access cases...
First in the industry to achieve dual certification for both reagents and analysers within its Atellica portfolio...
Developed with PacBio's PureTarget technology, the new test enhances identification of complex DNA repeat expansions to support accurate diagnosis and care for patients with neurological disorders ...
Strategic alliance enhances in-home screening with advanced molecular diagnostics, AI-driven insights, and flexible testing options to improve outcomes for patients and underserved communities. ...
Designed for seamless remote use, the ‘Anywhere powered by Linus Health™’ platform brings early detection of cognitive decline to payers, pharma, wellness providers, and consumers—anytime, anywhere. ...
Breakthrough findings for QyScore® and QyPredict® highlight enhanced accuracy in brain segmentation and early identification of cognitive decline, paving the way for improved clinical trials and patient outcomes in Alzheimer’s disease. ...
Vinmec Central Park pioneers breakthrough treatment using AutoGuide™ system, offering new hope for children with drug-resistant epilepsy and marking a significant leap towards global neurological care standards. ...
